Table 2 Proportion of patients receiving different 5-FU- and capecitabine-based chemotherapeutic regimens
From: Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
Treatment protocol | Patients | |
|---|---|---|
n | % | |
5-FU based treatment regimen | 196 | Â |
 5-FU bolus | 3 | 1.5 |
 24-h continuous infusion | 9 | 4.6 |
 5-FU + folinic acid + oxaliplatin | 118 | 60.2 |
 5-FU + folinic acid + irinotecan | 37 | 18.9 |
 Other 5-FU combo therapy | 29 | 14.8 |
Capecitabine based treatment regimen | 331 | Â |
 Capecitabine monotherapy | 11 | 3.3 |
 Capecitabine + oxaliplatin | 310 | 93.7 |
 Other capecitabine combo therapy | 10 | 3.0 |